Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). (Q46848592)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). |
scientific article |
Statements
1 reference
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). (English)
1 reference
1 reference
Salim Yusuf
1 reference
Origin Trial Investigators
1 reference
Matthew C Riddle
1 reference
Lars Ryden
1 reference
Jackie Bosch
1 reference
26 November 2007
1 reference
1 reference
155
1 reference
26-32, 32.e1-6
1 reference
1
1 reference
Identifiers
1 reference
1 reference